367 related articles for article (PubMed ID: 28129109)
1. Motor-Coordinative and Cognitive Dysfunction Caused by Mutant TDP-43 Could Be Reversed by Inhibiting Its Mitochondrial Localization.
Wang W; Arakawa H; Wang L; Okolo O; Siedlak SL; Jiang Y; Gao J; Xie F; Petersen RB; Wang X
Mol Ther; 2017 Jan; 25(1):127-139. PubMed ID: 28129109
[TBL] [Abstract][Full Text] [Related]
2. Sex-Specific Early Retinal Dysfunction in Mutant TDP-43 Transgenic Mice.
Gao J; Leinonen H; Wang EJ; Ding M; Perry G; Palczewski K; Wang X
J Alzheimers Dis; 2024; 97(2):927-937. PubMed ID: 38143367
[TBL] [Abstract][Full Text] [Related]
3. Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice.
Xu YF; Zhang YJ; Lin WL; Cao X; Stetler C; Dickson DW; Lewis J; Petrucelli L
Mol Neurodegener; 2011 Oct; 6():73. PubMed ID: 22029574
[TBL] [Abstract][Full Text] [Related]
4. Single-copy expression of an amyotrophic lateral sclerosis-linked TDP-43 mutation (M337V) in BAC transgenic mice leads to altered stress granule dynamics and progressive motor dysfunction.
Gordon D; Dafinca R; Scaber J; Alegre-Abarrategui J; Farrimond L; Scott C; Biggs D; Kent L; Oliver PL; Davies B; Ansorge O; Wade-Martins R; Talbot K
Neurobiol Dis; 2019 Jan; 121():148-162. PubMed ID: 30290270
[TBL] [Abstract][Full Text] [Related]
5. Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS.
Ke YD; van Hummel A; Stevens CH; Gladbach A; Ippati S; Bi M; Lee WS; Krüger S; van der Hoven J; Volkerling A; Bongers A; Halliday G; Haass NK; Kiernan M; Delerue F; Ittner LM
Acta Neuropathol; 2015 Nov; 130(5):661-78. PubMed ID: 26437864
[TBL] [Abstract][Full Text] [Related]
6. The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity.
Wang W; Wang L; Lu J; Siedlak SL; Fujioka H; Liang J; Jiang S; Ma X; Jiang Z; da Rocha EL; Sheng M; Choi H; Lerou PH; Li H; Wang X
Nat Med; 2016 Aug; 22(8):869-78. PubMed ID: 27348499
[TBL] [Abstract][Full Text] [Related]
7. Neuronal over-expression of Oxr1 is protective against ALS-associated mutant TDP-43 mislocalisation in motor neurons and neuromuscular defects in vivo.
Williamson MG; Finelli MJ; Sleigh JN; Reddington A; Gordon D; Talbot K; Davies KE; Oliver PL
Hum Mol Genet; 2019 Nov; 28(21):3584-3599. PubMed ID: 31642482
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of ALS-associated p.M337V human TDP-43 in mice worsens disease features compared to wild-type human TDP-43 mice.
Janssens J; Wils H; Kleinberger G; Joris G; Cuijt I; Ceuterick-de Groote C; Van Broeckhoven C; Kumar-Singh S
Mol Neurobiol; 2013 Aug; 48(1):22-35. PubMed ID: 23475610
[TBL] [Abstract][Full Text] [Related]
9. ALS/FTLD-linked TDP-43 regulates neurite morphology and cell survival in differentiated neurons.
Han JH; Yu TH; Ryu HH; Jun MH; Ban BK; Jang DJ; Lee JA
Exp Cell Res; 2013 Aug; 319(13):1998-2005. PubMed ID: 23742895
[TBL] [Abstract][Full Text] [Related]
10. An ALS-linked mutation in TDP-43 disrupts normal protein interactions in the motor neuron response to oxidative stress.
Feneberg E; Gordon D; Thompson AG; Finelli MJ; Dafinca R; Candalija A; Charles PD; Mäger I; Wood MJ; Fischer R; Kessler BM; Gray E; Turner MR; Talbot K
Neurobiol Dis; 2020 Oct; 144():105050. PubMed ID: 32800996
[TBL] [Abstract][Full Text] [Related]
11. Effects of mutant TDP-43 on the Nrf2/ARE pathway and protein expression of MafK and JDP2 in NSC-34 cells.
Tian YP; Che FY; Su QP; Lu YC; You CP; Huang LM; Wang SG; Wang L; Yu JX
Genet Mol Res; 2017 May; 16(2):. PubMed ID: 28510254
[TBL] [Abstract][Full Text] [Related]
12. ALS-linked TDP-43
Watanabe S; Oiwa K; Murata Y; Komine O; Sobue A; Endo F; Takahashi E; Yamanaka K
Mol Brain; 2020 Jan; 13(1):8. PubMed ID: 31959210
[TBL] [Abstract][Full Text] [Related]
13. Mutant TDP-43 within motor neurons drives disease onset but not progression in amyotrophic lateral sclerosis.
Ditsworth D; Maldonado M; McAlonis-Downes M; Sun S; Seelman A; Drenner K; Arnold E; Ling SC; Pizzo D; Ravits J; Cleveland DW; Da Cruz S
Acta Neuropathol; 2017 Jun; 133(6):907-922. PubMed ID: 28357566
[TBL] [Abstract][Full Text] [Related]
14. TDP-43 inhibitory peptide alleviates neurodegeneration and memory loss in an APP transgenic mouse model for Alzheimer's disease.
Gao J; Wang L; Gao C; Arakawa H; Perry G; Wang X
Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165580. PubMed ID: 31678156
[TBL] [Abstract][Full Text] [Related]
15. Transgenic rat model of neurodegeneration caused by mutation in the TDP gene.
Zhou H; Huang C; Chen H; Wang D; Landel CP; Xia PY; Bowser R; Liu YJ; Xia XG
PLoS Genet; 2010 Mar; 6(3):e1000887. PubMed ID: 20361056
[TBL] [Abstract][Full Text] [Related]
16. TARDBP pathogenic mutations increase cytoplasmic translocation of TDP-43 and cause reduction of endoplasmic reticulum Ca²⁺ signaling in motor neurons.
Mutihac R; Alegre-Abarrategui J; Gordon D; Farrimond L; Yamasaki-Mann M; Talbot K; Wade-Martins R
Neurobiol Dis; 2015 Mar; 75():64-77. PubMed ID: 25526708
[TBL] [Abstract][Full Text] [Related]
17. TDP-43 causes differential pathology in neuronal versus glial cells in the mouse brain.
Yan S; Wang CE; Wei W; Gaertig MA; Lai L; Li S; Li XJ
Hum Mol Genet; 2014 May; 23(10):2678-93. PubMed ID: 24381309
[TBL] [Abstract][Full Text] [Related]
18. The vulnerability of motor and frontal cortex-dependent behaviors in mice expressing ALS-linked mutation in TDP-43.
Wong P; Ho WY; Yen YC; Sanford E; Ling SC
Neurobiol Aging; 2020 Aug; 92():43-60. PubMed ID: 32422502
[TBL] [Abstract][Full Text] [Related]
19. Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS.
Robertson J; Sanelli T; Xiao S; Yang W; Horne P; Hammond R; Pioro EP; Strong MJ
Neurosci Lett; 2007 Jun; 420(2):128-32. PubMed ID: 17543992
[TBL] [Abstract][Full Text] [Related]
20. Neuronal Expression of UBQLN2
Picher-Martel V; Renaud L; Bareil C; Julien JP
Mol Neurobiol; 2019 Jul; 56(7):4680-4696. PubMed ID: 30377984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
